Whole-exome and transcriptome sequencing of refractory diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma. Although rituximab therapy improves clinical outcome, some patients develop resistant DLBCL; however, the genetic alterations in these patients are not well documented. To identify the genetic background of refrac...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Park, Ha Young, Lee, Seung-Bok, Yoo, Hae-Yong, Kim, Seok-Jin, Kim, Won-Seog, Kim, Jong-Il, Ko, Young-Hyeh
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2016
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5349924/
https://ncbi.nlm.nih.gov/pubmed/27835906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13239
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky